CONMED Corp. (CNMD) Altrus Thermal Tissue Fusion System Given Marketing Clearance by FDA

December 3, 2010 7:10 AM EST Send to a Friend
CONMED Corporation (NASDAQ: CNMD) announced that their Altrus Thermal Tissue Fusion System has been granted marketing clearance from the U.S. Food and Drug Administration.

The company believes that the current marketplace for energy based instruments approximates $1.5 billion.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA

Add Your Comment